AI-Powered Hepatitis C Single-Encounter Test-and-Treat
A legfontosabb adatok
- Hol
- Lexington (Egyesült Államok)A helyszín megnézése
- Fázis
- 4. fázis
Neked szólhat?
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 22 és 65 év között vagy?
Forrás: NCT07793643: ki vehet részt
Helyszínek itt: Egyesült Államok
- University of KentuckyLexington, Egyesült ÁllamokContact: Patrick GraceNo longer taking part
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Patrick Grace
- Azonosító
- NCT07793643
- A regiszteradat frissítve
- 2026. augusztus 28.
- Eredeti leírás
This study will evaluate a single-visit approach to hepatitis C treatment in patients seen in the emergency department. Participants with hepatitis C will receive rapid testing and, if eligible, hepatitis C medication before leaving the emergency department. The study will also use a smart pillbox, an AI-powered virtual agent, and community health worker support to help participants take their medication as prescribed. Participants will have follow-up visits and testing to assess medication adherence and whether the hepatitis C infection is cured.A teljes eredeti leírásKevesebb
This study will evaluate a single-visit approach to hepatitis C treatment in patients seen in the emergency department. Participants with hepatitis C will receive rapid testing and, if eligible, hepatitis C medication before leaving the emergency department. The study will also use a smart pillbox, an AI-powered virtual agent, and community health worker support to help participants take their medication as prescribed. Participants will have follow-up visits and testing to assess medication adherence and whether the hepatitis C infection is cured.
Bevonási feltételek: Age 22-65 years old, presenting to the Emergency Department (ED) who are undergoing antibody testing as part of universal screening; Patients to be discharged from the ED or ED Observational units.
Kizáró feltételek: Known prior liver biopsy showing cirrhosis; •Pregnancy; Followed by hospice or transplant, have a life expectancy < 1 year; Chronic Kidney Disease (CKD) or on dialysis; Allergy to study medications; Known clinical evidence of cirrhosis (egliver nodularity and/or splenomegaly on imaging, platelet count <150,000/m3, etc.); Capacity to Consent; Emergency Severity Index (ESI) Level one (high acuity patients); Known noninvasive serologic tests above proprietary cutoffs indicating cirrhosis (example - FibroSure, Enhanced Liver Fibrosis Test, etc.); Known or suspected Hepatocellular carcinoma; Patients admitted to the hospital.